Suzetrigine, a Selective Pain Signal Inhibitor of NaV1.8 Shows Proof-of-concept for Treatment of Painful Diabetic Peripheral Neuropathy (S11.002)
DOI: 10.1212/wnl.0000000000210760
文献链接: https://www.neurology.org/doi/10.1212/WNL.0000000000210760
其他信息:
出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Roy Freeman; Richard Rauck; Charles Argoff; Simon Tian; Xiaopeng Miao; Hannah Bouldin Olivet; Carmen Bozic; Robert Dworkin

